Cargando…

Dynamic regulation and functions of mRNA m6A modification

N(6)-Methyladenosine (m6A), the most abundant internal modification associated with eukaryotic mRNAs, has emerged as a dynamic regulatory mechanism controlling the expression of genes involved in many physiological activities by affecting various steps of mRNA metabolism, including splicing, export,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shanshan, Lv, Wei, Li, Tao, Zhang, Shubing, Wang, Huihui, Li, Xuemei, Wang, Lianzi, Ma, Dongyue, Zang, Yan, Shen, Jilong, Xu, Yuanhong, Wei, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800407/ https://www.ncbi.nlm.nih.gov/pubmed/35093087 http://dx.doi.org/10.1186/s12935-022-02452-x

Ejemplares similares

MicroRNA-146a promotes proliferation, migration, and invasion of HepG2 via regulating FLAP
por: Wang, Huihui, et al.
Publicado: (2022)

Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma
por: Wang, Lianzi, et al.
Publicado: (2021)

The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer
por: Lv, Wei, et al.
Publicado: (2021)

Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries
por: Li, Tao, et al.
Publicado: (2020)

Multiple roles of microRNA-146a in immune responses and hepatocellular carcinoma
por: Wang, Huihui, et al.
Publicado: (2019)

The genetic sequence, origin, and diagnosis of SARS-CoV-2
por: Wang, Huihui, et al.
Publicado: (2020)

Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection
por: Li, Tao, et al.
Publicado: (2020)

The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study
por: Wang, Lianzi, et al.
Publicado: (2022)

Analysis of mRNA m(6)A modification and mRNA expression profiles in middle ear cholesteatoma
por: Xie, Shumin, et al.
Publicado: (2023)

Dynamic m(6)A modification regulates local translation of mRNA in axons
por: Yu, Jun, et al.
Publicado: (2018)

Association between glycosylated hemoglobin A1c and bone biochemical markers in type 2 diabetic postmenopausal women: a cross-sectional study
por: Wang, Lianzi, et al.
Publicado: (2019)

LRPPRC facilitates tumor progression and immune evasion through upregulation of m(6)A modification of PD-L1 mRNA in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

Aberrant Regulation of mRNA m(6)A Modification in Cancer Development
por: Luo, Junyun, et al.
Publicado: (2018)

METTL3-mediated m(6)A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy
por: Jiang, Ling, et al.
Publicado: (2022)

PLAA suppresses ovarian cancer metastasis via METTL3-mediated m(6)A modification of TRPC3 mRNA
por: Shen, Zhangjin, et al.
Publicado: (2022)

Modulation of translational decoding by m(6)A modification of mRNA
por: Jain, Sakshi, et al.
Publicado: (2023)

Reading and writing of mRNA m(6)A modification orchestrate maternal-to-zygotic transition in mice
por: Zhu, Wencheng, et al.
Publicado: (2023)

mRNA modifications: Dynamic regulators of gene expression?
por: Hoernes, Thomas Philipp, et al.
Publicado: (2016)

Control of mRNA translation by dynamic ribosome modification
por: Grenga, Lucia, et al.
Publicado: (2020)

New Twists in Detecting mRNA Modification Dynamics
por: Anreiter, Ina, et al.
Publicado: (2021)

N(6)-Methyladenosine mRNA Modification: From Modification Site Selectivity to Neurological Functions
por: Zhang, Zeyu, et al.
Publicado: (2023)

Diverse molecular functions of m(6)A mRNA modification in cancer
por: Han, Seung Hun, et al.
Publicado: (2020)

MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14
por: Liu, Te, et al.
Publicado: (2021)

RNA modification in mRNA cancer vaccines
por: Mei, Yingxue, et al.
Publicado: (2023)

New mRNA modification?
por: Leslie, Mitch
Publicado: (2007)

m(6)A regulator-mediated methylation modification patterns and tumor immune microenvironment in sarcoma
por: Li, Zhehong, et al.
Publicado: (2022)

Limited effects of m(6)A modification on mRNA partitioning into stress granules
por: Khong, Anthony, et al.
Publicado: (2022)

KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA
por: Cheng, Xiaoyu, et al.
Publicado: (2019)

Genetic Analyses Support the Contribution of mRNA N(6)-methyladenosine (m(6)A) Modification to Human Disease Heritability
por: Zhang, Zijie, et al.
Publicado: (2020)

The CTBP2-PCIF1 complex regulates m(6)Am modification of mRNA in head and neck squamous cell carcinoma
por: Li, Kang, et al.
Publicado: (2023)

m(6)A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover
por: Ke, Shengdong, et al.
Publicado: (2017)

Dynamic assembly of the mRNA m(6)A methyltransferase complex is regulated by METTL3 phase separation
por: Han, Dasol, et al.
Publicado: (2022)

METTL3-mediated m(6)A modification is required for cerebellar development
por: Wang, Chen-Xin, et al.
Publicado: (2018)

Transcriptome Profiling of m(6)A mRNA Modification in Bovine Mammary Epithelial Cells Treated with Escherichia coli
por: Li, Ting, et al.
Publicado: (2021)

Mouse Maternal High-Fat Intake Dynamically Programmed mRNA m(6)A Modifications in Adipose and Skeletal Muscle Tissues in Offspring
por: Li, Xiao, et al.
Publicado: (2016)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
por: Liu, Albert, et al.
Publicado: (2022)

The role of mRNA m(6)A methylation in the nervous system
por: Li, Jiashuo, et al.
Publicado: (2019)

m(6)A modification suppresses ocular melanoma through modulating HINT2 mRNA translation
por: Jia, Ruobing, et al.
Publicado: (2019)

The Emerging Role of m6A Modification in Endocrine Cancer
por: Ji, Xiaoyu, et al.
Publicado: (2023)

N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
por: Jin, Huan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iom1uso282apqnfmm1jmsekv6g